PACS Group, Inc. (PACS) Stock Competitors & Peer Comparison
See (PACS) competitors and their performances in Stock Market.
Peer Comparison Table: Financial - Conglomerates Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PACS | $43.22 | -1.37% | 6.8B | 36.74 | $1.18 | N/A |
| TPGXL | $23.10 | -0.90% | 15.7B | N/A | N/A | +5.27% |
| BIPH | $16.08 | -1.35% | 5.9B | N/A | N/A | +7.85% |
| TAKNX | $8.01 | +0.00% | 2.3B | N/A | N/A | N/A |
| MSDL | $15.57 | +2.37% | 1.3B | 7.93 | $1.96 | +12.15% |
| BBCQW | $2.26 | -5.04% | 1.3B | N/A | N/A | N/A |
| RILYK | $25.23 | +0.16% | 787.6M | N/A | N/A | N/A |
| RILYM | $25.11 | +0.00% | 753M | N/A | N/A | N/A |
| CCXIU | $16.54 | -1.02% | 693M | N/A | N/A | N/A |
| CCXI | $15.55 | -4.19% | 651.5M | N/A | N/A | N/A |
Stock Comparison
PACS vs TPGXL Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, TPGXL has a market cap of 15.7B. Regarding current trading prices, PACS is priced at $43.22, while TPGXL trades at $23.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas TPGXL's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to TPGXL's ROE of +0.13%. Regarding short-term risk, PACS is more volatile compared to TPGXL. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TPGXL's competition here
PACS vs BIPH Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, BIPH has a market cap of 5.9B. Regarding current trading prices, PACS is priced at $43.22, while BIPH trades at $16.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas BIPH's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BIPH's ROE of +0.06%. Regarding short-term risk, PACS is more volatile compared to BIPH. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BIPH's competition here
PACS vs TAKNX Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, TAKNX has a market cap of 2.3B. Regarding current trading prices, PACS is priced at $43.22, while TAKNX trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas TAKNX's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to TAKNX's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to TAKNX. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TAKNX's competition here
PACS vs MSDL Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, MSDL has a market cap of 1.3B. Regarding current trading prices, PACS is priced at $43.22, while MSDL trades at $15.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas MSDL's P/E ratio is 7.93. In terms of profitability, PACS's ROE is +0.27%, compared to MSDL's ROE of +0.05%. Regarding short-term risk, PACS is more volatile compared to MSDL. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MSDL's competition here
PACS vs BBCQW Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, BBCQW has a market cap of 1.3B. Regarding current trading prices, PACS is priced at $43.22, while BBCQW trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas BBCQW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BBCQW's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to BBCQW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check BBCQW's competition here
PACS vs RILYK Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, RILYK has a market cap of 787.6M. Regarding current trading prices, PACS is priced at $43.22, while RILYK trades at $25.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas RILYK's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYK's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYK. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYK's competition here
PACS vs RILYM Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, RILYM has a market cap of 753M. Regarding current trading prices, PACS is priced at $43.22, while RILYM trades at $25.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas RILYM's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYM's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYM. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYM's competition here
PACS vs CCXIU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, CCXIU has a market cap of 693M. Regarding current trading prices, PACS is priced at $43.22, while CCXIU trades at $16.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas CCXIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CCXIU's ROE of +0.00%. Regarding short-term risk, PACS is less volatile compared to CCXIU. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check CCXIU's competition here
PACS vs CCXI Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, CCXI has a market cap of 651.5M. Regarding current trading prices, PACS is priced at $43.22, while CCXI trades at $15.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas CCXI's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CCXI's ROE of +0.00%. Regarding short-term risk, PACS is less volatile compared to CCXI. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check CCXI's competition here
PACS vs RILYO Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, RILYO has a market cap of 573.5M. Regarding current trading prices, PACS is priced at $43.22, while RILYO trades at $25.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas RILYO's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYO's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYO. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYO's competition here
PACS vs TMS Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, TMS has a market cap of 561.3M. Regarding current trading prices, PACS is priced at $43.22, while TMS trades at $7.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas TMS's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to TMS's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to TMS. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check TMS's competition here
PACS vs NWAX-UN Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, NWAX-UN has a market cap of 506.9M. Regarding current trading prices, PACS is priced at $43.22, while NWAX-UN trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas NWAX-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to NWAX-UN's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to NWAX-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NWAX-UN's competition here
PACS vs NWAX Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, NWAX has a market cap of 505M. Regarding current trading prices, PACS is priced at $43.22, while NWAX trades at $10.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas NWAX's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to NWAX's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to NWAX. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NWAX's competition here
PACS vs CRAN Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, CRAN has a market cap of 478.4M. Regarding current trading prices, PACS is priced at $43.22, while CRAN trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas CRAN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CRAN's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to CRAN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CRAN's competition here
PACS vs VACHU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, VACHU has a market cap of 475.5M. Regarding current trading prices, PACS is priced at $43.22, while VACHU trades at $14.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas VACHU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to VACHU's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to VACHU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check VACHU's competition here
PACS vs ANSC Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, ANSC has a market cap of 475.3M. Regarding current trading prices, PACS is priced at $43.22, while ANSC trades at $11.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas ANSC's P/E ratio is 52.00. In terms of profitability, PACS's ROE is +0.27%, compared to ANSC's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to ANSC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ANSC's competition here
PACS vs ANSCU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, ANSCU has a market cap of 474.9M. Regarding current trading prices, PACS is priced at $43.22, while ANSCU trades at $11.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas ANSCU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ANSCU's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to ANSCU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ANSCU's competition here
PACS vs LEGT-UN Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, LEGT-UN has a market cap of 467.4M. Regarding current trading prices, PACS is priced at $43.22, while LEGT-UN trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas LEGT-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to LEGT-UN's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to LEGT-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check LEGT-UN's competition here
PACS vs CXIIU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, CXIIU has a market cap of 452.4M. Regarding current trading prices, PACS is priced at $43.22, while CXIIU trades at $10.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas CXIIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CXIIU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to CXIIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CXIIU's competition here
PACS vs CXII Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, CXII has a market cap of 444.6M. Regarding current trading prices, PACS is priced at $43.22, while CXII trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas CXII's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CXII's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to CXII. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CXII's competition here
PACS vs DBCAU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, DBCAU has a market cap of 437.9M. Regarding current trading prices, PACS is priced at $43.22, while DBCAU trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas DBCAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DBCAU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to DBCAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DBCAU's competition here
PACS vs MESH Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, MESH has a market cap of 431.7M. Regarding current trading prices, PACS is priced at $43.22, while MESH trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas MESH's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to MESH's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MESH. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MESH's competition here
PACS vs XRPNW Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, XRPNW has a market cap of 418M. Regarding current trading prices, PACS is priced at $43.22, while XRPNW trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas XRPNW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to XRPNW's ROE of +0.05%. Regarding short-term risk, PACS is less volatile compared to XRPNW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check XRPNW's competition here
PACS vs XRPN Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, XRPN has a market cap of 412.5M. Regarding current trading prices, PACS is priced at $43.22, while XRPN trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas XRPN's P/E ratio is 80.38. In terms of profitability, PACS's ROE is +0.27%, compared to XRPN's ROE of +0.05%. Regarding short-term risk, PACS is more volatile compared to XRPN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XRPN's competition here
PACS vs BBCQ Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, BBCQ has a market cap of 396.7M. Regarding current trading prices, PACS is priced at $43.22, while BBCQ trades at $10.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas BBCQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BBCQ's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to BBCQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BBCQ's competition here
PACS vs MBAV Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, MBAV has a market cap of 389.9M. Regarding current trading prices, PACS is priced at $43.22, while MBAV trades at $10.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas MBAV's P/E ratio is 83.46. In terms of profitability, PACS's ROE is +0.27%, compared to MBAV's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to MBAV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MBAV's competition here
PACS vs SDHIR Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, SDHIR has a market cap of 389.8M. Regarding current trading prices, PACS is priced at $43.22, while SDHIR trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas SDHIR's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SDHIR's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to SDHIR. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SDHIR's competition here
PACS vs TVACW Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, TVACW has a market cap of 375.7M. Regarding current trading prices, PACS is priced at $43.22, while TVACW trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas TVACW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to TVACW's ROE of +0.05%. Regarding short-term risk, PACS is more volatile compared to TVACW. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TVACW's competition here
PACS vs ENHA Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, ENHA has a market cap of 373.1M. Regarding current trading prices, PACS is priced at $43.22, while ENHA trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas ENHA's P/E ratio is -10.74. In terms of profitability, PACS's ROE is +0.27%, compared to ENHA's ROE of -0.86%. Regarding short-term risk, PACS is less volatile compared to ENHA. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check ENHA's competition here
PACS vs FCRS-UN Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, FCRS-UN has a market cap of 369.6M. Regarding current trading prices, PACS is priced at $43.22, while FCRS-UN trades at $10.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas FCRS-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to FCRS-UN's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to FCRS-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check FCRS-UN's competition here
PACS vs CRANU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, CRANU has a market cap of 368.2M. Regarding current trading prices, PACS is priced at $43.22, while CRANU trades at $10.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas CRANU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CRANU's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to CRANU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CRANU's competition here
PACS vs CEPT Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, CEPT has a market cap of 360.2M. Regarding current trading prices, PACS is priced at $43.22, while CEPT trades at $11.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas CEPT's P/E ratio is -107.09. In terms of profitability, PACS's ROE is +0.27%, compared to CEPT's ROE of +0.01%. Regarding short-term risk, PACS is less volatile compared to CEPT. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check CEPT's competition here
PACS vs DMAAU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, DMAAU has a market cap of 359.3M. Regarding current trading prices, PACS is priced at $43.22, while DMAAU trades at $10.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas DMAAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DMAAU's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to DMAAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DMAAU's competition here
PACS vs SCPQW Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, SCPQW has a market cap of 355.7M. Regarding current trading prices, PACS is priced at $43.22, while SCPQW trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas SCPQW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SCPQW's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to SCPQW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check SCPQW's competition here
PACS vs ARCI Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, ARCI has a market cap of 354.7M. Regarding current trading prices, PACS is priced at $43.22, while ARCI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas ARCI's P/E ratio is -4373.91. In terms of profitability, PACS's ROE is +0.27%, compared to ARCI's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to ARCI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ARCI's competition here
PACS vs SBXE Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, SBXE has a market cap of 349.8M. Regarding current trading prices, PACS is priced at $43.22, while SBXE trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas SBXE's P/E ratio is 507.00. In terms of profitability, PACS's ROE is +0.27%, compared to SBXE's ROE of -0.09%. Regarding short-term risk, PACS is more volatile compared to SBXE. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SBXE's competition here
PACS vs PLMKW Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, PLMKW has a market cap of 341.1M. Regarding current trading prices, PACS is priced at $43.22, while PLMKW trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas PLMKW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to PLMKW's ROE of +0.03%. Regarding short-term risk, PACS is less volatile compared to PLMKW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check PLMKW's competition here
PACS vs RREV Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, RREV has a market cap of 333M. Regarding current trading prices, PACS is priced at $43.22, while RREV trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas RREV's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RREV's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to RREV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RREV's competition here
PACS vs ANSCW Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, ANSCW has a market cap of 330.9M. Regarding current trading prices, PACS is priced at $43.22, while ANSCW trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas ANSCW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ANSCW's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to ANSCW. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ANSCW's competition here
PACS vs PACH Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, PACH has a market cap of 324.5M. Regarding current trading prices, PACS is priced at $43.22, while PACH trades at $10.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas PACH's P/E ratio is 34.20. In terms of profitability, PACS's ROE is +0.27%, compared to PACH's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to PACH. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PACH's competition here
PACS vs IACQU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, IACQU has a market cap of 317.9M. Regarding current trading prices, PACS is priced at $43.22, while IACQU trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas IACQU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to IACQU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to IACQU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IACQU's competition here
PACS vs VACI Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, VACI has a market cap of 317.8M. Regarding current trading prices, PACS is priced at $43.22, while VACI trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas VACI's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to VACI's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to VACI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check VACI's competition here
PACS vs SAC Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, SAC has a market cap of 315.2M. Regarding current trading prices, PACS is priced at $43.22, while SAC trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas SAC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SAC's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SAC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SAC's competition here
PACS vs LPAAW Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, LPAAW has a market cap of 311.8M. Regarding current trading prices, PACS is priced at $43.22, while LPAAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas LPAAW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to LPAAW's ROE of +0.07%. Regarding short-term risk, PACS is less volatile compared to LPAAW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check LPAAW's competition here
PACS vs DBCA Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, DBCA has a market cap of 309.3M. Regarding current trading prices, PACS is priced at $43.22, while DBCA trades at $9.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas DBCA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DBCA's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to DBCA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DBCA's competition here
PACS vs LPBBU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, LPBBU has a market cap of 308.3M. Regarding current trading prices, PACS is priced at $43.22, while LPBBU trades at $10.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas LPBBU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to LPBBU's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to LPBBU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check LPBBU's competition here
PACS vs LPBB Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, LPBB has a market cap of 308.2M. Regarding current trading prices, PACS is priced at $43.22, while LPBB trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas LPBB's P/E ratio is 35.73. In terms of profitability, PACS's ROE is +0.27%, compared to LPBB's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to LPBB. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check LPBB's competition here
PACS vs RILYT Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, RILYT has a market cap of 304.3M. Regarding current trading prices, PACS is priced at $43.22, while RILYT trades at $20.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas RILYT's P/E ratio is 2.85. In terms of profitability, PACS's ROE is +0.27%, compared to RILYT's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYT. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYT's competition here
PACS vs SVACW Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, SVACW has a market cap of 303.6M. Regarding current trading prices, PACS is priced at $43.22, while SVACW trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas SVACW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SVACW's ROE of -5.09%. Regarding short-term risk, PACS is less volatile compared to SVACW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check SVACW's competition here
PACS vs ALOVU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, ALOVU has a market cap of 302.9M. Regarding current trading prices, PACS is priced at $43.22, while ALOVU trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas ALOVU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ALOVU's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to ALOVU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ALOVU's competition here
PACS vs FERAR Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, FERAR has a market cap of 302.4M. Regarding current trading prices, PACS is priced at $43.22, while FERAR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas FERAR's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to FERAR's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to FERAR. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check FERAR's competition here
PACS vs RILYG Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, RILYG has a market cap of 302.1M. Regarding current trading prices, PACS is priced at $43.22, while RILYG trades at $24.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas RILYG's P/E ratio is 20.83. In terms of profitability, PACS's ROE is +0.27%, compared to RILYG's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYG. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYG's competition here
PACS vs RILYN Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, RILYN has a market cap of 300.2M. Regarding current trading prices, PACS is priced at $43.22, while RILYN trades at $25.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas RILYN's P/E ratio is 2.52. In terms of profitability, PACS's ROE is +0.27%, compared to RILYN's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYN's competition here
PACS vs CAIIU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, CAIIU has a market cap of 296.5M. Regarding current trading prices, PACS is priced at $43.22, while CAIIU trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas CAIIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CAIIU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to CAIIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CAIIU's competition here
PACS vs RILYP Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, RILYP has a market cap of 292.1M. Regarding current trading prices, PACS is priced at $43.22, while RILYP trades at $14.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas RILYP's P/E ratio is 88.95. In terms of profitability, PACS's ROE is +0.27%, compared to RILYP's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYP. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYP's competition here
PACS vs ACAAU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, ACAAU has a market cap of 289.3M. Regarding current trading prices, PACS is priced at $43.22, while ACAAU trades at $10.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas ACAAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ACAAU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to ACAAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ACAAU's competition here
PACS vs RILY Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, RILY has a market cap of 288.6M. Regarding current trading prices, PACS is priced at $43.22, while RILY trades at $7.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas RILY's P/E ratio is 0.68. In terms of profitability, PACS's ROE is +0.27%, compared to RILY's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILY. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILY's competition here
PACS vs RILYL Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, RILYL has a market cap of 287.8M. Regarding current trading prices, PACS is priced at $43.22, while RILYL trades at $14.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas RILYL's P/E ratio is 88.64. In terms of profitability, PACS's ROE is +0.27%, compared to RILYL's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYL. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYL's competition here
PACS vs KPET Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, KPET has a market cap of 286.6M. Regarding current trading prices, PACS is priced at $43.22, while KPET trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas KPET's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to KPET's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to KPET. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check KPET's competition here
PACS vs XCBE Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, XCBE has a market cap of 280.7M. Regarding current trading prices, PACS is priced at $43.22, while XCBE trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas XCBE's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to XCBE's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to XCBE. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XCBE's competition here
PACS vs HVIIR Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, HVIIR has a market cap of 276.3M. Regarding current trading prices, PACS is priced at $43.22, while HVIIR trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas HVIIR's P/E ratio is -17.13. In terms of profitability, PACS's ROE is +0.27%, compared to HVIIR's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to HVIIR. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HVIIR's competition here
PACS vs NHIV Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, NHIV has a market cap of 275.6M. Regarding current trading prices, PACS is priced at $43.22, while NHIV trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas NHIV's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to NHIV's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to NHIV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NHIV's competition here
PACS vs XSLL Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, XSLL has a market cap of 274.9M. Regarding current trading prices, PACS is priced at $43.22, while XSLL trades at $9.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas XSLL's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to XSLL's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to XSLL. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XSLL's competition here
PACS vs HVIIU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, HVIIU has a market cap of 272.7M. Regarding current trading prices, PACS is priced at $43.22, while HVIIU trades at $10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas HVIIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to HVIIU's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to HVIIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HVIIU's competition here
PACS vs HVII Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, HVII has a market cap of 272.2M. Regarding current trading prices, PACS is priced at $43.22, while HVII trades at $10.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas HVII's P/E ratio is -484.26. In terms of profitability, PACS's ROE is +0.27%, compared to HVII's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to HVII. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HVII's competition here
PACS vs OSPRU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, OSPRU has a market cap of 270.3M. Regarding current trading prices, PACS is priced at $43.22, while OSPRU trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas OSPRU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to OSPRU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to OSPRU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check OSPRU's competition here
PACS vs SOUL-UN Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, SOUL-UN has a market cap of 265.7M. Regarding current trading prices, PACS is priced at $43.22, while SOUL-UN trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas SOUL-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SOUL-UN's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to SOUL-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SOUL-UN's competition here
PACS vs GIXXU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, GIXXU has a market cap of 262.5M. Regarding current trading prices, PACS is priced at $43.22, while GIXXU trades at $10.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas GIXXU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to GIXXU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to GIXXU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check GIXXU's competition here
PACS vs SORN Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, SORN has a market cap of 261.4M. Regarding current trading prices, PACS is priced at $43.22, while SORN trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas SORN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SORN's ROE of +1.22%. Regarding short-term risk, PACS is more volatile compared to SORN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SORN's competition here
PACS vs ARTC Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, ARTC has a market cap of 261M. Regarding current trading prices, PACS is priced at $43.22, while ARTC trades at $9.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas ARTC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ARTC's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to ARTC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ARTC's competition here
PACS vs FACTU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, FACTU has a market cap of 260.2M. Regarding current trading prices, PACS is priced at $43.22, while FACTU trades at $11.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas FACTU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to FACTU's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to FACTU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check FACTU's competition here
PACS vs ALOV Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, ALOV has a market cap of 259.7M. Regarding current trading prices, PACS is priced at $43.22, while ALOV trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas ALOV's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ALOV's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to ALOV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ALOV's competition here
PACS vs PLMK Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, PLMK has a market cap of 258.4M. Regarding current trading prices, PACS is priced at $43.22, while PLMK trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas PLMK's P/E ratio is 42.64. In terms of profitability, PACS's ROE is +0.27%, compared to PLMK's ROE of +0.03%. Regarding short-term risk, PACS is less volatile compared to PLMK. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check PLMK's competition here
PACS vs CAES Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, CAES has a market cap of 258M. Regarding current trading prices, PACS is priced at $43.22, while CAES trades at $10.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas CAES's P/E ratio is -5040.00. In terms of profitability, PACS's ROE is +0.27%, compared to CAES's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to CAES. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CAES's competition here
PACS vs DYNCW Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, DYNCW has a market cap of 256.3M. Regarding current trading prices, PACS is priced at $43.22, while DYNCW trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas DYNCW's P/E ratio is -0.23. In terms of profitability, PACS's ROE is +0.27%, compared to DYNCW's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to DYNCW. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DYNCW's competition here
PACS vs AACI Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, AACI has a market cap of 254.5M. Regarding current trading prices, PACS is priced at $43.22, while AACI trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas AACI's P/E ratio is 496.02. In terms of profitability, PACS's ROE is +0.27%, compared to AACI's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to AACI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check AACI's competition here
PACS vs KEYYU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, KEYYU has a market cap of 253.5M. Regarding current trading prices, PACS is priced at $43.22, while KEYYU trades at $10.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas KEYYU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to KEYYU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to KEYYU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check KEYYU's competition here
PACS vs HCICU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, HCICU has a market cap of 253.2M. Regarding current trading prices, PACS is priced at $43.22, while HCICU trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas HCICU's P/E ratio is 43.78. In terms of profitability, PACS's ROE is +0.27%, compared to HCICU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to HCICU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HCICU's competition here
PACS vs PTOR Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, PTOR has a market cap of 253.1M. Regarding current trading prices, PACS is priced at $43.22, while PTOR trades at $9.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas PTOR's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to PTOR's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to PTOR. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PTOR's competition here
PACS vs OIMAW Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, OIMAW has a market cap of 250M. Regarding current trading prices, PACS is priced at $43.22, while OIMAW trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas OIMAW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to OIMAW's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to OIMAW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check OIMAW's competition here
PACS vs CAQ Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, CAQ has a market cap of 248.1M. Regarding current trading prices, PACS is priced at $43.22, while CAQ trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas CAQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CAQ's ROE of +9.93%. Regarding short-term risk, PACS is more volatile compared to CAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CAQ's competition here
PACS vs HCIC Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, HCIC has a market cap of 247.5M. Regarding current trading prices, PACS is priced at $43.22, while HCIC trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas HCIC's P/E ratio is 29.32. In terms of profitability, PACS's ROE is +0.27%, compared to HCIC's ROE of +1.74%. Regarding short-term risk, PACS is more volatile compared to HCIC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HCIC's competition here
PACS vs LEGT Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, LEGT has a market cap of 247.2M. Regarding current trading prices, PACS is priced at $43.22, while LEGT trades at $9.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas LEGT's P/E ratio is 72.34. In terms of profitability, PACS's ROE is +0.27%, compared to LEGT's ROE of +0.04%. Regarding short-term risk, PACS is less volatile compared to LEGT. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check LEGT's competition here
PACS vs SBXE-UN Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, SBXE-UN has a market cap of 246M. Regarding current trading prices, PACS is priced at $43.22, while SBXE-UN trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas SBXE-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SBXE-UN's ROE of -0.09%. Regarding short-term risk, PACS is more volatile compared to SBXE-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SBXE-UN's competition here
PACS vs DRDB Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, DRDB has a market cap of 243.1M. Regarding current trading prices, PACS is priced at $43.22, while DRDB trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas DRDB's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DRDB's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to DRDB. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DRDB's competition here
PACS vs DRDBU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, DRDBU has a market cap of 242.9M. Regarding current trading prices, PACS is priced at $43.22, while DRDBU trades at $10.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas DRDBU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DRDBU's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to DRDBU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DRDBU's competition here
PACS vs SSACU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, SSACU has a market cap of 241.9M. Regarding current trading prices, PACS is priced at $43.22, while SSACU trades at $10.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas SSACU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SSACU's ROE of -0.05%. Regarding short-term risk, PACS is more volatile compared to SSACU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SSACU's competition here
PACS vs SAAQ Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, SAAQ has a market cap of 238.8M. Regarding current trading prices, PACS is priced at $43.22, while SAAQ trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas SAAQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SAAQ's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SAAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SAAQ's competition here
PACS vs GSRVU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, GSRVU has a market cap of 237.8M. Regarding current trading prices, PACS is priced at $43.22, while GSRVU trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas GSRVU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to GSRVU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to GSRVU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check GSRVU's competition here
PACS vs MACI Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, MACI has a market cap of 236.8M. Regarding current trading prices, PACS is priced at $43.22, while MACI trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas MACI's P/E ratio is 43.57. In terms of profitability, PACS's ROE is +0.27%, compared to MACI's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to MACI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MACI's competition here
PACS vs IRHO Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, IRHO has a market cap of 236.4M. Regarding current trading prices, PACS is priced at $43.22, while IRHO trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas IRHO's P/E ratio is 250.75. In terms of profitability, PACS's ROE is +0.27%, compared to IRHO's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to IRHO. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IRHO's competition here
PACS vs ILLU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, ILLU has a market cap of 235M. Regarding current trading prices, PACS is priced at $43.22, while ILLU trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas ILLU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ILLU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to ILLU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ILLU's competition here
PACS vs ADAC Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, ADAC has a market cap of 231.2M. Regarding current trading prices, PACS is priced at $43.22, while ADAC trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas ADAC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ADAC's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to ADAC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ADAC's competition here
PACS vs BLRK Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, BLRK has a market cap of 230.9M. Regarding current trading prices, PACS is priced at $43.22, while BLRK trades at $10.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas BLRK's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BLRK's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to BLRK. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BLRK's competition here
PACS vs VHCP Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, VHCP has a market cap of 230.2M. Regarding current trading prices, PACS is priced at $43.22, while VHCP trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas VHCP's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to VHCP's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to VHCP. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check VHCP's competition here
PACS vs LPCV Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, LPCV has a market cap of 229.8M. Regarding current trading prices, PACS is priced at $43.22, while LPCV trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas LPCV's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to LPCV's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to LPCV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check LPCV's competition here
PACS vs MEVOU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, MEVOU has a market cap of 227.9M. Regarding current trading prices, PACS is priced at $43.22, while MEVOU trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas MEVOU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to MEVOU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MEVOU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MEVOU's competition here
PACS vs CCAQW Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, CCAQW has a market cap of 227.2M. Regarding current trading prices, PACS is priced at $43.22, while CCAQW trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas CCAQW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CCAQW's ROE of +0.03%. Regarding short-term risk, PACS is less volatile compared to CCAQW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check CCAQW's competition here
PACS vs XCBEU Comparison July 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 6.8B. In comparison, XCBEU has a market cap of 225.7M. Regarding current trading prices, PACS is priced at $43.22, while XCBEU trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 36.74, whereas XCBEU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to XCBEU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to XCBEU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XCBEU's competition here